Genomic origin and transcriptional regulation of two variants of cGMP- binding cGMP-specific phosphodiesterases

European Journal of Biochemistry

Volumn 262, Issue 3, 1999, Pages 866-873

  Kotera, Jun ^a   Fujishige, Kotomi ^a   Imai, Yuji ^a   Kawai, Eri ^a   Michibata, Hideo ^a   Akatsuka, Hiroyuki ^a   Yanaka, Noriyuki ^a   Omori, Kenji ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

cAMP; cGMP; Gene; PDE5; Phosphodiesterase; Transcriptional regulation

Indexed keywords

GUANOSINE PHOSPHATE; PHOSPHODIESTERASE;

AMINO TERMINAL SEQUENCE; ARTICLE; DNA SEQUENCE; ENZYME SYNTHESIS; EXON; GENE EXPRESSION; GENOME; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE;

EID: 0033564377     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1999.00450.x     Document Type: Article

References (39)

1. 1. Kukovetz, W.R., Holzmann, S., Wurm, A. & Poch, G. (1979) Evidence for cyclic GMP-mediated relaxant effects of nitro-compounds in coronary smooth muscle. Naunyn Schmiedeberg's Arch. Pharmacol. 310, 129-138.
2. 2. Schram, M. & Selinger, Z. (1984) Messenger transmission: receptor controlled adenylate cyclase system. Science 225, 1350-1356.
3. 3. Beavo, J.A. (1995) Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol. Rev. 75, 725-748.
4. 4. Soderling, S.H., Bayuga, S.J. & Beavo, J.A. (1998) Cloning and characterizacion of cAMP-specific cyclic nucleotide phosphodiesterase. Proc. Natl Acad. Sci. USA 95, 8991-8996.
5. 5. Fisher, A.D., Smith, J.F., Pillar, J.S., St. Denis, S.H. & Cheng, J.B. (1998) Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase. Biochem. Biophys. Res. Commun. 246, 570-577.
6. 6. Soderling, S.H., Bayuga, S.J. & Beavo, J.A. (1998) Identification and characterization of a novel family of cyclic nucleotide phosphodiesterases. J. Biol. Chem. 273, 15553-15558.
7. 7. Fisher, A.D., Smith, J.F., Pillar, J.S., St. Denis, S.H. & Cheng, J.B. (1998) Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase. J. Biol. Chem. 273, 15559-15564.
8. 8. White, D.G. & Martin, W. (1989) Differential control and calcium-dependence of production of endothelium-derived relaxing factor and prustacyclin by pig aortic endothelial cells. Br. J. Pharmacol. 97, 683-690.
9. 9. Hartell, N.A. (1996) Inhibition of cGMP breakdown promotes the induction of cerebellar long-term depression. J. Neurosci. 16, 2881-2890.
10. 10. Boolell, M., Allen, M.J., Ballard, S.A., Gepi-Attee, S., Muirhead, G.J., Naylor, A.M., Osterloh, I.H. & Gingell, C. (1996) Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int. J. Impot. Res. 8, 47-52.
11. 11. Kotera, J., Yanaka, N., Fujishige, K., Imai, Y., Akatsuka, H., Ishizuka, T., Kawashima, K. & Omori, K. (1997) Expression of rat cGMP-binding cGMP-specific phosphodiesterase mRNA in Purkinje cell layers during postnatal neuronal development. Eur. J. Biochem. 249, 434-442.
12. 12. Yanaka, N., Kotera, J., Ohtsuka, A., Akatsuka, H., Imai, Y., Michibata, H., Fujishige, K., Kawai, E., Takebayashi, S., Okumura, K. & Omori, K. (1998) Expression, structure and chromosomal localization of the human cGMP-binding cGMP-specific phosphodiesterase. Eur. J. Biochem. 255, 391-399.
13. 13. Kotera, J., Fujishige, K., Akatsuka, H., Imai, Y., Yanaka, N. & Omori, K. (1998) Novel alternative splice variants of cGMP-binding cGMP-specific phosphodiesterase. J. Biol. Chem. 273, 26982-26990.
14. 14. McAllister-Lucas, L.M., Sonnenburg, W.K., Kudlecek, A., Seger, D., Trong, H.L., Colbran, J.L., Thomas, M.K., Walsh, K.A., Francis, S.H., Corbin, J.D. & Beavo, J.A. (1993) The structure of a bovine lung cGMP-binding, cGMP-specific phosphodiesterase deduced from a cDNA clone. J. Biol. Chem. 268, 22863-22873.
15. 15. Yan, C., Bentley, J.K., Sonnenburg, W.K. & Beavo, J.A. (1994) Differential expression of the 61 kDa and 63 kDa calmodulin-dependent phosphodiesterase in the mouse brain. J. Neurosci. 14, 973-984.
16. 16. Polli, J.W. & Kincaid, R.L. (1994) Expression of a calmodulin-dependent phosphodiesterase isoform (PDE1B1) correlates with brain regions having extensive dopominergic innervation. J. Neurosci. 14, 1251-1261.
17. 17. Reinhardt, R.R., Chin, E., Zhou, J., Taira, M., Murata, T., Manganiello, V.C. & Bond, C.A. (1995) Distinctive anatomical patterns of gene expression for cGMP-inhibited cyclic nucleotide phosphodiesterases. J. Clin. Invest. 95, 1528-1538.
18. 18. McPhee, I., Pooley, L., Lobban, M., Bolger, G. & Houslay, M.D. (1995) Identification, characterization, a novel splice variant of the PDE4A cyclic AMP phosphodiesterase family. Biochem. J. 310, 965-974.
19. 19. Yan, C., Zhao, A.Z., Bentley, J.K. & Beavo, J.A. (1996) The calmodulin-dependent phosphodiesterase gene PDEIC encodes several functionally different splice variants in a tissue-specific manner. J. Biol. Chem. 271, 25699-25706.
20. 20. Bolger, G.B., McPhee, I. & Houslay, M.D. (1996) Alternative splicing of cAMP-specific phosphodiesterase mRNA transcripts. J. Biol. Chem. 271, 1065-1071.
21. 21. Huston, E., Pooley, L., Julien, P., Scotland, G., McPhee, I., Sullivan, M., Bolger, G. & Houslay, M.D. (1996) The human cyclic AMP-specific phosphodiesterase PDE-46 (HSPDE4A4B) expressed in transfected COS7 cells occurs as both paniculate and cytosolic species that exhibit distinct kinetics of inhibition by the antidepressant rolipram. J. Biol. Chem. 271, 31334-31344.
22. 22. Han, P., Zhu, X. & Michaeli, T. (1997) Alternative splicing of the high affinity cAMP-specific phosphodiesterase (PDE7A) mRNA in human skeletal muscle and heart. J. Biol. Chem. 272, 16152-16157.
23. 23. Degerman, E., Belfrage, P. & Manganiello, V.C. (1997) Structure, localization and regulation of cGMP-inhibited phosphodiesterase (PDE3). J. Biol. Chem. 272, 6823-6826.
24. 24. O'Connell, J.C., McCallum, J.F., McPhee, I., Wakefield, J., Houslay, E.S., Wishart, W., Bolger, G., Frame, M. & Houslay, M.D. (1996) The SH3 domain of src tyrosyl protein kinase interacts with the N-terminal splice region of the PDE4A cAMP-specific phosphodiesterase RPDE-6 (RNPDE4A5). Biochem. J. 318, 255-262.
25. 25. Scotland, G. & Houslay, M.D. (1995) Chimeric constructs shown that the unique N-terminal domain of the cyclic AMP phosphodiesterase RD1 (RNPDE4A1A; rPDE-IVa1) can confer membrane association upon the normally cytosolic protein chloramphenicol acetyltransferase. Biochem. J. 308, 673-681.
26. 26. Shakur, Y., Pryde, J.G. & Houslay, M.D. (1993) Engineered deletion of the unique N-terminal domain of the cyclic AMP-specific phosphodiesterase RD1 prevents plasma membrane association and the attainment of enhanced thermostability without altering its sensitivity to inhibition by rolipram. Biochem. J. 292, 677-686.
27. 27. Stacey, P., Rulten, S., Dapling, A. & Phillips, S.C. (1998) Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase (PDE5). Biochem. Biophys. Res. Commun. 247, 249-254.
28. 28. Loughney, K., Hill, T.R., Florio, V.R., Uher, L., Rosman, G.J., Wolda, S.L., Jones, B.A., Howard, M.L., McAllister-Lucas, L.M., Sonnenburg, W.K., Francis, S.H., Corbin, J.D., Beavo, J.A. & Ferguson, K. (1998) Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3′,5′-cyclic nucleotide phosphodiesterase. Gene 216, 139-147.
29. 29. Owens, G.K., Loeb, B., Gordon, D. & Thompson, M.M. (1986) Expression of smooth muscle-specific alpha-isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation. J. Cell. Biol. 102, 343-352.
30. 30. Padgett, R.A., Grabowski, P.J., Konarska, M.M., Seilaer, S. & Sharp, P.A. (1986) Splicing of messenger RNA precursors. Annu. Rev. Biochem. 55, 1119-1150.
31. 31. Sanchez, L., de la Monte, S.M., Filippov, G., Jones, R.C., Zapol, W.M. & Bloch, K.D. (1998) Cyclic-GMP-binding, cyclic-GMP-specific phosphodiesterase (PDE5) gene expression is regulated during rat pulmonary development. Pediatr. Res. 43, 163-168.
32. 32. Pilz, R.B., Suhasini, M., Idriss, S., Meinkoth, J.L. & Boss, G.R. (1995) Nitric oxide and cGMP analogs activate transcription from AP-1-responsive promoters in mammalian cells. FASEB J. 9, 552-558.
33. 33. Gudi, T., Huvar, I., Meinecke, M., Lohmann, S.M., Boss, G.R. & Pilz, R.B. (1996) Regulation of gene expression by cGMP-dependent protein kinase. J. Biol. Chem. 271, 4597-4600.
34. 34. Immenschuh, S., Hinke, V., Ohlmann, A., Gifhorn-Katz, S., Katz, N., Jungermann, K. & Kietzmann, T. (1998) Transcriptional activation of the haem oxygenase-1 gene by cGMP via a cAMP response element/ activator protein-1 element in primary cultures of rat hepatocytes. Biochem. J. 334, 141-146.
35. 35. Wyatt, T.A., Naftilan, A.J., Francis, S.H. & Corbin, J.D. (1998) ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells. Am. J. Physiol. 274, H448-H455.
36. 36. Geng, Y., Zhou, L., Thompson, W.J. & Lotz, M. (1998) Cyclic GMP and cGMP-binding phosphodiesterase are required for interleukin-1-induced nitric oxide synthesis in human articular chondrocytes. J. Biol. Chem. 273, 27484-27491.
37. 37. Durante, W., Christodoulides, N., Cheng, K., Peyton, K.J., Sunahara, R.K. & Schafer, A.I. (1997) cAMP induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle. Am. J. Physiol. 273, H317-H323.
38. 38. Soff, G.A., Cornwell, T.L., Cundiff, D.L., Gately, S. & Lincoln, T.M. (1997) Smooth muscle cell expression of type I cyclic GMP-dependent protein kinase is suppressed by continuous exposure to nitrovasodilators, theophylline, cyclic GMP, and cyclic AMP. J. Clin. Invest. 100, 2580-2587.
39. 39. Conti, M.A. & Adelstein, R.S. (1981) The relationship between calmodulin binding and phosphorylation of smooth muscle myosin kinase by the catalytic subunit of 3′: 5′ cAMP-dependent protein kinase. J. Biol. Chem. 256, 3178-3181.